Histological examination of the liver after experimental administration of MK-801 and dexamethasone

Joanna Sekita-Krzak1, Krystyna Czerny, Iwona Zebrowska-Lupina

  • 1Department of Histology and Embryology with the Laboratory for Experimental Cytology, Skubiszewski Medical University of Lublin.

Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina
|September 9, 2005
PubMed

Insights

MK-801, an NMDA receptor antagonist, causes liver cell changes and worsens dexamethasone-induced liver damage in mice. This research highlights potential hepatic toxicity from MK-801 exposure.

Area of Science:

  • Histopathology
  • Toxicology
  • Pharmacology

Background:

  • The liver is a key organ for drug metabolism and detoxification.
  • NMDA receptor antagonists and corticosteroids can have systemic effects, including on the liver.
  • Understanding drug-induced liver injury is crucial for patient safety.

Purpose of the Study:

  • To histologically assess the effects of MK-801 (NMDA receptor antagonist) on the liver.
  • To evaluate the combined influence of MK-801 and dexamethasone on liver morphology.
  • To determine if MK-801 exacerbates dexamethasone-induced liver toxicity.

Main Methods:

  • Adult male Albino-Swiss mice were used for the experiment.
  • MK-801 was administered at 0.3 mg/kg/24 h for 8 days.
  • Mice received a toxic dose of dexamethasone (120 mg/kg/24 h).
  • Liver slices were stained with hematoxylin and eosin and examined via light microscopy.

Main Results:

  • MK-801 induced morphological changes in hepatocytes, including increased cytoplasmic transparency.
  • MK-801 caused narrowing of liver sinusoids.
  • MK-801 intensified liver damage from toxic dexamethasone doses, leading to focal hepatocyte necrosis.

Conclusions:

  • MK-801 can induce distinct histological alterations in the mouse liver.
  • MK-801 potentiates the hepatotoxic effects of high-dose dexamethasone.
  • Combined exposure may lead to significant liver damage, including necrosis.

Related Concept Videos